Funding Opportunities

The Funding Opportunities section provides a list of some external funding opportunities available to our researchers. If you have any questions regarding external funding opportunities please contact Mike Folinas or Sam D’Alfonso.

All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal.

  • Alpha Phi Foundation: Heart to Heart Grant Program. This program aims to provide $100,000 in grant funding to support innovative research studies and educational programs that aim to inform health care professionals and women about the causes, prevention and treatment of heart disease.
    Deadline for applications: November 5, 2019.
  • Alex’s Lemonade Stand Foundation for Childhood Cancer. 
    • Innovation Grants. These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers. Amount: Up to USD $250,000 over two years. Deadline for Letters of Intent: November 4, 2019.
  • Alzheimer’s Society Research Program 2020 Research Competition  The Alzheimer’s Society Research Program 2020 Research Competition has now been launched. ASRP has the overall objective to support Canadian studies that promise new insights into causes, prevention, diagnosis, treatment and management of Alzheimer’s disease and related dementias.  The programs offered include Doctoral Awards, Postdoctoral Awards, New Investigator Operating Grants and a Proof of Concept Grant. More details available here.
    Internal Deadline: November 1, 2019; Sponsor Deadline: November 8, 2019 by 11:59pm.
  • American Fibromyalgia Syndrome Association (AFSA): Research Grants. Visit their website for priority areas of funding. Amount: Up to USD $50,000 for one year. Deadline for Letters of Intent: Continuous.
  • American Society of Clinical Oncology (ASCO): Advanced Clinical Research Award (ACRA). The ACRA is a topic-specific competition designed to support physician-scientists committed to performing original, clinical cancer research in an area not currently funded. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Amount: USD $450,000 for three years. Deadline for applications: October 31, 2019.
  • Banting and Best Diabetes Centre (BBDC): Sun Life Financial New Investigator Award 2020-2022, and Reuben & Helene Dennis Scholar in Diabetes Research 2020-2022. These awards are intended to support new clinician-scientists and basic scientists in the early stages of their careers. One Sun Life Financial New Investigator Award and one Reuben & Helene Dennis Scholar award will be made available for this competition. Funds may be used for diabetes research support and/or the salary of a clinician-scientist conducting diabetes research. Deadline for applications: October 22, 2019 at 4pm. 
  • Banting & Best Diabetes Centre (BBDC): Pilot and Feasibility Grants 2020/2021 This program provides funding of up to $40,000 per application to enable eligible investigators to explore new initiatives in the area of biomedical research/basic sciences. Funding is not to be used as bridging or emergency funding, nor is it intended as funding for ongoing studies. To be eligible to apply, the principal applicant must hold a faculty appointment with the University of Toronto at the level of associate, assistant, or full professor. Those who received a 2019/2020 BBDC Pilot and Feasibility Grant as principal applicant are not eligible to apply for this competition as a principal or co-applicant. Deadline for applications: November 12, 2019 at 4pm.
  • Bill & Melinda Gates Foundation, Global Grand Challenges: Innovations for Improving the Impact of Health Campaigns (Round 24). They are seeking innovative solutions that accelerate the improvement of coverage, reach, efficiency, and effectiveness of health campaigns. Specifically, we are looking for innovations in approaches, practices, or tools that dramatically improve the planning and microplanning, implementation / operations, and monitoring and evaluation that will lead to improved effectiveness of campaigns. Amount: Initial grants, Phase I: $100,000 USD for 18 months. Phase I projects that show promise will be eligible to apply for follow-on funding; Phase II. Deadline for applications: November 13, 2019.
  • Biocodex Microbiota Foundation – Microbiome in human health and diseases  Biocodex Microbiota Foundation is calling on inspired researchers at Canadian institutions in the microbiome field to submit proposals for funding their projects. This Canadian grant of 25,000 €.will be awarded to an early career investigator studying a 1 – 2 year long research project within the topic of microbiome in human health and diseases. The grant is intended as a seeding or bridging grant, to help investigators become independent or advance in the progression of their career. Holders of CIHR Foundation grants or total funding exceeding 200k per year may not apply. Sponsor Deadline: October 31, 2019.
  • BrightFocus Foundation.
    • National Glaucoma Research (NRG): Standard Awards. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Please note that applicants to the NGR program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines. Up to USD $200,000 over two years. Deadline for applications: November 8, 2019.
    • Alzheimer’s Disease Research (ADR): Postdoctoral Fellowship Awards. Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant’s own independent research career. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency). All other applicants are encouraged to apply for a standard award. Amount: USD $200,000 over two years. Deadline for proposals: November 4, 2019.
  • Canadian Hemophilia Society (CHS). Grants.
    • Dream of a Cure Research Program. The objective is to support basic scientific research in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology), and other congenital and acquired bleeding disorders. Amount: Up to $150,000 over two or three years. Deadline for applications: November 15, 2019.
    • The CHS/Pfizer Care until Cure Research Program. The objective to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Amount: Up to $150,000 over two or three years. Deadline for applications: November 15, 2019.
  • Cancer Research Society: Translational Research Partnership Program. The goal of this program is to support collaborative and pivotal translational research projects. Amount: Up to a maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society. Projects must be translational research and may include clinical trial studies, aim the development of a therapeutic and/or novel technologies, and have excellent preliminary data to support the proposed project. There is no deadline associated with this program. Letters of Intent from applicants with high potential projects will be invited to submit an official application for funding, which is then peer-reviewed.
  • Cancer Research Institute (CRI): Clinic and Laboratory Integration Program (CLIP) CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation, CRI has secured designated funding that will provide for additional CLIP grants focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma. Amount: $200,000 over two years. Deadline for LOIs: November 1, 2019; Invited application deadline: February 15, 2020.
  • Cancer Research Institute: Technology Impact Award The program is designed to encourage collaboration between technology developers and clinical cancer immunologists in addressing the gap between technology development and clinical application of cancer immunotherapies. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients. The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation personalized cancer immunotherapies. Amount: USD $200,000 over two years. Deadline for Letters of Intent: November 15, 2019. Selected applicants will be invited to submit a full research proposal, due March 15, 2020.
  • Crohn’s and Colitis Foundation of America Inc.
    • Litwin IBD Pioneers Initiative. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data. Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is open to investigators from other disciplines new to the IBD field, as well as countries outside the United States. There is no fixed upper or lower limit of funding, but awards are generally not funded above USD $130,000 for up to two years. Deadline for Letters of Intent: November 5, 2019.
    • Senior Research Awards. The goal of the Senior Research Award (SRA) is to provide established researchers with funds to generate findings that have an impact on the field of IBD to advance the mission of the Foundation. This impact could be evaluated by various measures, including follow-on funding from other sources, such as the National Institutes of Health (NIH), publications with high impact, and related patents or citations within patents. Total maximum award per year: USD $115,830 for up to 3 years. Deadline for Letters of Intent: November 5, 2019.
  • Employment and Social Development Canada – Sustainable Development Goals Funding Program – Grants  In 2015, Canada and all other United Nations Member States, committed to implementing the 2030 Agenda for Sustainable Development, which set 17 Sustainable Development Goals (SDGs) to eliminate poverty, protect the planet and ensure prosperity by the year 2030.  Applications are currently being accepted, on an ongoing basis, from organizations interested in receiving up to $100,000 in grant funding from the SDG Funding Program for projects that are up to 12 months in duration.
    Sponsor Deadline: Ongoing
  • Epilepsy Foundation: New Therapy Commercialization Grant and Epilepsy Seal of Innovation Award. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Amount: New Commercialization Grant – Up to USD $350,000 for up to two years; Epilepsy Seal of Innovation Award – Up to USD $200,000 for one year. Deadline for Letters of Intent: January 28, 2020.
  • Harry J. Lloyd Charitable Trust: Melanoma Research Grants. There are three types of grants offered: Career Development (May include salary support for promising young melanoma investigators); Basic Sciences; and Translational Research. Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection. Amount: Up to USD $125,000 per year.
    Deadline for applications: November 1, 2019.
  • New challenges from Innovative Solutions Canada  The Innovative Solutions Canada program provides funding to startups and small businesses to provide solutions to federal government agencies.  The program facilitates the early development, testing and validation of prototypes, as well as accelerating commercialization for innovative technologies.
    The program is open to incorporated startups and small businesses (<499 employees).
    Current challenges include:

    For more information and to receive alerts for new challenges, visit the program website.

  • JDRF: Strategic Research Agreements – Multi-Project SRA. The JDRF SRA for multiple projects provides a mechanism to stimulate new collaborations between clinical and basic scientists and/or between scientists from diverse backgrounds as a means to conceive and develop new approaches to major challenges, potential breakthroughs, or persistent obstacles to progress along the various paths to prevent, treat or cure Type 1 diabetes and its complications. Available funding for the Strategic Research Agreement will be reviewed on a per-application basis. Deadline for concept papers/proposals: November 4, 2019; or February 3, 2020.
  • JDRF: Research Grants
  • McLaughlin Centre Research Funding Opportunity: Request for Letters of Intent The McLaughlin Centre is pleased to announce its tenth research funding competition. The competition will be based on invited grant applications passing an initial letter of intent stage. Both steps will go through committee peer-review adjudicated by the Director.
    The emphasis in this Call will be Moving Genomics to Populations:
    1.  Building clinical cohort resources (e.g. DNA, RNA), including pilot genome-wide datasets (e.g. whole genome sequence, epigenome, microbiome), and clinical phenotypes, are appropriate;
    2.   Building databases and computational tools to collect and analyze whole genome datasets for health and administrative database linkage. Small leveraged grants are emphasized;
    3.   Development of statistical and computational approaches used in genetic risk score analyses for research and disease prediction modeling. Team-based or linked training grants are emphasized.
    Letter of Intent Deadline: December 6, 2019; Application Deadline: March 6, 2020 (invited applicants only)
  • Melanoma Research Alliance (MRA): Pilot Awards. Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of -concept, which may then leverage additional funding through more traditional avenues. Amount: Up to USD $50,000 per year for two years. Deadline for proposals: November 18, 2019.
  • The Michael J. Fox Foundation for Parkinson’s Research (MJFF): Ken Griffin Alpha-synuclein Imaging Competition. The Competition seeks to accelerate work to develop a selective alpha-synuclein PET tracer. MJFF has prioritized alpha-synuclein imaging as the most likely imaging approach to have an impact for therapeutic development. MJFF encourages multidisciplinary teams to apply to this program and is particularly interested in collaborations between academic and industry groups that have access to diverse compound libraries. Projects can include compound screening, tissue binding studies, lead identification and optimization, in vivo testing in appropriate animal models, and first-in-human testing of candidate tracers. A total of USD $8.5 million is available for the first two years of the program with the possibility of an additional $1.5 million for the project that shows the most promising results during the initial funding period. Deadline for proposals: January 17, 2019.
  • Mitacs Panel Discussion  You are invited to join the MITACS Panel Discussion Session that will be held on Wednesday November 13, 2019 from 10:30-11:30am in Sidney Smith Hall, 100 St. George Street, Rm SS2098.  Learn how Mitacs funding can accelerate your research program and create excellent opportunities for your trainees!
    Please RSVP by November 8th if you wish to attend.
  • Mitacs – Japan Society for the Promotion of Science (JSPS) – Call for Applications  Mitacs is now accepting applications for the Mitacs-JSPS Summer Program, which supports researchers in Canada to undertake 10-week research projects in Japan in Summer 2020.
    The program is open to graduate students and postdoctoral fellows in all disciplines at Canadian academic institutions. Internal deadline: November 20, 2019; Sponsor Deadline: November 27, 2019
  • Motor Neurone Disease (MND) Association: Biomedical Research Project Grants. The MND Association supports biomedical research on Amyotrophic Lateral Sclerosis and related conditions, in all relevant disciplines. The objectives of the MND Association research funding programme are to support research aimed at understanding the causes of MND, elucidating disease mechanisms and facilitating the translation of therapeutic strategies from the laboratory to the clinic. The essential purpose of the grant is to support a single project, i.e. a piece of work designed to answer a single question or a small group of related questions. Applicants can be based outside the UK and Ireland, provided the project is unique in concept or design (i.e. no similar research is being performed in the UK) and involves a significant aspect of collaboration with a UK institute. Upper amount GBP £255,000 for up to 3 years.
    Deadline for applications: October 25, 2019.
  • National PKU Alliance: 
    • NPKUA Post-Doctoral Fellowships. The NPKUA is seeking proposals that will help us meet the above strategic goals, promote and encourage young investigators into PKU-related research, to close the existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects. Both United States and international academic institutions will be considered. Amount: Up to USD $55,000 per year for two years.
      Deadline for proposals: November 1, 2019.
    • Research Projects. The overall funding strategy of the NPKUA is to support research that will promote advances in the treatment and management of phenylketonuria, with the long term goal of facilitating the development of a cure.  The average award is USD $40,000; however exceptional applications may be funded at a higher amount if the budget request is justified. Initial grants are awarded for one year with potential of renewal based on progress made during the first year. In addition, the Alliance supports some strategic projects on an on-going basis.
      Deadline for proposals: November 1, 2019.
  • New challenges from Innovative Solutions Canada. The Innovative Solutions Canada program provides funding to startups and small businesses to provide solutions to federal government agencies. The program facilitates the early development, testing and validation of prototypes, as well as accelerating commercialization for innovative technologies. Up to $150,000 in support to develop a proof of concept, and if approved, up to $1 million to develop a protoype. The program is open to incorporated startups and small businesses (<499 employees). Current challenges include:
    •    Foot-and-mouth disease vaccine matching (Closes October 24, 2019)
    •    Data Centre Discovery Tool with Options Analysis (Closes October 24, 2019)
    •    Hybrid Ceramic Powder Processing System (Closes October 29, 2019)
    •    Stable Liposomes as Drug Carriers (Closes October 29, 2019)
  • National Institutes of Health (NIH) – Information Session with Dr. Matthew Fenton from NIH  The University of Toronto is proud to welcome Dr. Matthew Fenton, Director of the Division of Extramural Activities in the National Institute of Allergy and Infectious Disease (NIAID), who will be presenting “NIH 101” to our Research Community. We invite all who wish to learn more about applying to NIH to attend this 60-minute session. Afterwards, Dr. Fenton will remain available to discuss questions with faculty, students, and post-doctoral fellows.
    This presentation will provide an overview of the NIH, its internal organization, its operations, how research priorities are established, and how funding decisions are made.
    Details of Event: Friday October 25, 2019 from 1 pm – 2 pm.
    Location: Sidney Smith Hall, Room 1087, 100 St. George Street
    This Session is also available through Skype for Business: Join Skype Meeting
    Please RSVP your in-person attendance of Skype participation to: Christine Kwan at c.kwan@utoronto.ca
  • NIH Various Opportunities  The National Institutes of Health has released the following requests for applications and program announcements:
    Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01) (RFA-AI-19-059) Application Receipt Date(s): January 17, 2020
    Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01) (RFA-DK-19-008) Submission Deadline: November 7, 2019.
    Aging, Driving and Early Detection of Dementia (R01) (RFA-AG-20-022) Submission Deadline: October 22, 2019
    The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed). (RFA-AG-20-044). Submission Deadline: January 21, 2020
    Biology of Aging in Reproductive Tissues (R01) (RFA-AG-20-036) Submission Deadline: January 29, 2020
    Brain Initiative: Research to Develop and Validate Advanced Human Cell-Based Assays To Model Brain Structure and Function (R01) (RFA-MH-20-140). Submission Deadline: November 1, 2019.
    BRAIN Initiative: Non-Invasive Neuromodulation – New Tools and Techniques for Spatiotemporal Precision (R01) (RFA-MH-20-310) Submission Deadlines: February 14, 2020
    Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01) (PAR-19-289). Submission Deadline: Standard deadline dates apply.
    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01) (PAR-19-325) Submission Deadlines:  February 11, 2020; September 30, 2020.
    Clinical Studies of Mental Illness (R01) (PAR-19-297) Submission Deadline: Standard dates apply
    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01) (PAR-19-325) Submission Deadline: September 30, 2019; February 11, 2020; September 30, 2020.
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24) (PAR-19-330). Submission Deadline: February 11, 2020, June 10, 2020, October 14, 2020.
    Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) (PAR-19-330). Submission Deadlines: February 11, 2020, June 10, 2020, October 14, 2020.
    Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01). (RFA-DA-20-015) Submission Deadline: October 23, 2019
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01) (PAR-20-026). Application Receipt Date(s): February 15 , 2020, September 15, 2020, September 15, 2021
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01)(PAR-20-027). Application Receipt Date(s): February 14, 2020, September 15, 2020, September 15, 2021
    Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3) (RFA-HL-20-025). Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s)
    Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB-SIMPLe) Research Coordinating Center (U24) (RFA-HL-20-026)
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s)
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01) (PAR-19-327). Submission Deadline: on a rolling basis, beginning on August 26, 2019
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) (PAR-19-327). Submission Deadlines: Applications will be accepted on a rolling basis, beginning on August 26, 2019
    Interpersonal Processes in Alzheimer’s Disease and Related Dementias Clinical Interactions and Care Partnerships (R01) (RFA-AG-20-006)
    Submission Deadline: October 23, 2019.
    Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01). (RFA-DA-20-008) Submission Deadline: November 14, 2019
    Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21). (RFA-DA-20-009) Submission Deadline: November 14, 2019
    Lipid Signaling in Healthspan and Longevity Regulation (R01) (RFA-AG-20-039) Submission Deadline: February 3, 2020
    Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01)
    (PAR-19-307)  Submission Deadline: January 14, 2020, January 14, 2021
    Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01) (PAR-19-357). Submission Deadline: AIDS Application Due Dates
    NCI Clinical and Translational Exploratory/Developmental Studies (R21) (PAR-19-356) Submission Deadline: February 20, 2020, June 19, 2020; October 20, 2020
    Neural Regulation of Cancer (R01) (PAR-19-353) Submission Deadline: May 27, 2020; October 21, 2020
    Neural Regulation of Cancer (R21) (PAR-19-354)Submission Deadline: May 27, 2020; October 21, 2020;
    NIA Multi-site Clinical Trial Implementation Grant (R01)  (PAR-19-302) Submission Deadline: Standard dates apply Non-Invasive Neurostimulation in AD/ADRD (R01) (PAR-19-298) Submission Deadline: Standard dates apply
    Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01) (RFA-AG-20-040) Submission Deadline: October 23, 2019
    Perception and Cognition Research to Inform Cancer Image Interpretation (R01) (PAR-19-387). Application Receipt Date(s): The first standard due date for this FOA is February 5, 2020
    Perception and Cognition Research to Inform Cancer Image Interpretation (R21) (PAR-19-389). Application Receipt Date(s): The first standard due date for this FOA is February 16, 2020
    Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21) (RFA-AG-20-041) Submission Deadline: October 23, 2019
    Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01) (RFA-AG-20-042)Submission Deadline: October 23, 2019
    Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03)
    (PAS-19-391) Application Receipt Date(s): Standard dates apply
    Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03) (PAS-19-392) Application Receipt Date(s): Standard dates apply.
    Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03) (PAS-19-393) Application Receipt Date(s): Standard dates apply
    Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) (PAR-19-309) Submission Deadline: Standard dates apply
    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)(PAR-19-328) Submission Deadlines: February 11, 2020, June 10, 2020
    Single-Site Investigator-Initiated Clinical Trials (R61/R33) (PAR-19-328) Submission Deadline: February 11, 2020, June 10, 2020
    Tobacco Regulatory Science (R01) (RFA-OD-19-028) Application Receipt Date(s): February 13, 2020, July 17, 2020, February 13, 2021
    Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21) (RFA-AI-19-065) Application Receipt Date(s): March 18, 2020

    Visit here to see the National Institutes of Health’s recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University’s Research Funding Opportunities found here.
  • NSERC Alliance grants: Canada’s Research Partnerships Program Alliance grants encourage greater collaboration in Canada’s R&D system by providing support for projects that include both generators and users of research results and knowledge. Alliance is designed to be more responsive and flexible for our research community and to accommodate a broader range of partners. It also includes incentives for collaborations with small and medium-sized enterprises and multi-sectoral partnerships, and offers an accelerated means for projects to scale and grow. For full details about the Alliance grants and how to apply please visit the new Alliance webpage. Alliance will be launched in a phased approach. On May 21st, Option 1 will be open for applications requesting $150,000 or more annually from NSERC. Option 1 for applications requesting less than $150,000 annually from NSERC, as well as Option 2, will be phased in gradually. Please continue to check the website for the latest information and sign up to the mailing list on the Alliance webpage.
  • NSERC Discovery Grant  The Discovery Grants Program supports ongoing programs of research with long-term goals rather than a single short-term project or collection of projects. These grants recognize the creativity and innovation that are at the heart of all research advances. Discovery Grants are considered “grants in aid” of research, as they provide long term operating funds and can facilitate access to funding from other programs, but are not meant to support the full costs of a research program.
    Internal Deadline: October 25, 2019; Sponsor Deadline: November 1, 2019
  • NSERC Research Tools and Instruments  The Research Tools and Instruments (RTI) grants program fosters and enhances the discovery, innovation and training capability of university researchers in the natural sciences and engineering by supporting the purchase of research equipment. Internal Deadline: October 18, 2019; Sponsor Deadline: October 25, 2019.
  • Ontario Centres of Excellence (OCE) – VIP Program Open for Applications  The Ontario Centres of Excellence (OCE) Voucher for Innovation and Productivity (VIP) Program is OPEN and ACCEPTING APPLICATIONS!The VIP Program replaces the previous VIP I and VIP II Programs, and focuses on helping Ontario companies develop, implement and commercialize technical innovations by supporting industry-academic collaborations.
    OCE VIP Program guidelines:

    • Applications are accepted at any time
    • Project duration: 6 to 24 months
    • OCE contribution: minimum of $20,000 up to a maximum of $150,000 per year towards the direct costs of research
    • Industry Partner contribution: minimum of 1:1 cash match to the OCE contribution, where at least 50% must be spent at the post-secondary institution
      • Example: OCE contribution is $100,000, Industry Partner must provide a minimum of $100,000 cash towards the direct costs + the standard University overhead rate of 40%, for a total Industry Partner contribution of $140,000

    Please note: the amount allocated towards overhead is not included in the OCE VIP application, but is documented in the related Sponsored Research Agreement between the University and the Industry Partner and should be discussed with the Industry Partner at the application stage
    When applying to the VIP Program, eligible applicants can also leverage funds from several federal Co-Funding Partners, through a streamlined, single application process. Current Co-Funding Partners include:

    • Mitacs Accelerate
      • Project duration: 6 to 12 months
      • Maximum investment: $7,500 per intern for each 4-6 month internship unit
      • Industry Partner matching: minimum of $7,500 per intern for each 4-6 month internship unit
    • Business Development Bank of Canada (BDC)
      • Industry Partners requiring a loan to support their contribution towards a VIP project, can apply online for a BDC loan of up to $100,000.
  • Ontario Molecular Pathology Research Network (OMPRN): 2019 Cancer Pathology Translational Research Grants (CPTRG) Stream1. Projects must be likely to advance the field of cancer diagnostic, prognostic or predictive testing. Collaborations between Ontario institutions, including the trans-institutional use of core resources, are encouraged as is leveraging of existing collaborative clinical trials networks. It is expected that most proposals will make use of primary human cancer samples. Amount: Up to $35,000 for one year. Deadline for applications: October 28, 2019.
  • Parkinson Canada Research Program The Parkinson Canada Research Program funds research into the cure, cause, progression, improved treatment and/or understanding of Parkinson’s disease, related disorders including Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), other Parkinson’s conditions and the impact these diseases have on society.  The Parkinson Canada Research program offers a number of programs including the Pilot Project Grant, New Investigators Award, Basic Research Fellowship, Graduate studentships and various partnerships.
    Sponsor Deadline: February 4, 2020
  • Partnership for Clean Competition – Funding Opportunities  The Partnership for Clean Competition funds Scientific and Social Science research that helps deter and detect doping in sport. Projects from any discipline meeting their research priorities are eligible for funding:
    They offer grants and fellowships three times annually:
    Pre-applications are due March 1st, July 1st, and November 1st; Full applications are due April 1st, August 1st, or December 1st
  • Prostate Cancer Foundation-Pfizer: PCF-Pfizer Global Challenge Awards. Approximately $2 million USD is allocated to this research grants program focused on investigating talazoparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in prostate cancer.  Through this funding mechanism, PCF and Pfizer will support approximately three innovative clinical investigations or clinical trial correlative research studies surrounding the use of talazoparib in prostate cancer. Teams must be composed of at least three investigators from non-profit academic research centers, including one young investigator. Applicants (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent). Deadline for Letters of Intent: December 3, 2019; Deadline for full proposals: March 23, 2020.
  • 2020 RBC Prize for Innovation and Entrepreneurship The 2020 RBC Prize for Innovation and Entrepreneurship is an annual business pitch competition offering $50,000 in prizes to recognize, reward, and accelerate the University of Toronto’s most innovative startups. Part of U of T Entrepreneurship Week True Blue Expo, the competition will take place Thursday, March 12 at MaRS. Selected individuals or teams will compete by showcasing their business idea via a five-minute pitch to a panel of judges for the following prizes:
    Early Stage Prizes*          Later Stage Prizes**
    1st Prize: $10,000             1st Prize: $25,000
    2nd Prize: $5,000              2nd Prize: $10,000
    Apply now for your chance to win prize money to take your startup to the next level!
    Deadline: Monday October 28, 2019.
  • SSHRC Connection Grants – Joint Initiatives  The Social Sciences and Humanities Research Council (SSHRC) is pleased to announce the Initiative for Digital Citizen Research (IDCR), a new joint initiative with the Department of Canadian Heritage (PCH) and one component of Canadian Heritage’s Digital Citizen Initiative. The IDCR aims to develop a better understanding of the impacts of online disinformation in Canada in order to better inform programs and policies, build Canada’s capacity to conduct research on – and related to – countering online disinformation and other related online harms, and help foster a community of researchers engaged with digital citizenship and online disinformation in Canada.
  • Healthy Cities Research Training Platform  The Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC) are jointly funding a national Healthy Cities Research Training Platform (HCRTP) to develop an interdisciplinary, cross-sectoral training initiative that will generate cutting-edge knowledge and build capacity for implementation science and solutions-based research.
    The application process for the HCRTP will consist of a Letter of Intent (LOI) stage, where up to six successful applicants will receive developmental grants, and a Full Application stage where one partnership will receive the full grant.
    The total amount available for this funding opportunity is $5,100,000. This amount may increase if additional funding partners participate. Of this amount:
    • $150,000 is available to fund six developmental grants of up to $25,000 at the LOI stage.
    • $4,950,000 is available for the Full Application which is enough to fund one grant. The maximum amount for the grant is $825,000 per year for up to six years.
    LOI Deadline: December 10, 2019 (Anticipated LOI Notice of Decision: January 31, 2020)
  • SSHRC Partnership Engage Grant  The Social Sciences and Humanities Research Council (SSHRC) is pleased to announce the partnership Engage Grants.  These grants are expected to respond to the objectives of the Insight program and the Connection program. Please note that Partnership Engage Grants cannot respond exclusively to the objectives of the Connection program.
    These grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. The small-scale, stakeholder-driven partnerships supported through Partnership Engage Grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. In addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.
    Sponsor Deadlines: December 15, March 15, June 15 by 8pm EST.
  • Simons Foundation Autism Research Initiative – Winter 2020 Pilot Grants  The Simons Foundation Autism Research Initiative is now accepting applications that address areas relevant to improving the scientific understanding, diagnosis and treatment of autism spectrum disorders. These areas include genetics and other factors contributing to risk; molecular and cellular mechanisms; synaptic and circuit physiology; sensory perception; cognition; behaviour; and clinical and translational studies.  Support innovative, high-impact, proposals requesting support for small-scale projects or early-stage experiments that build on preliminary data.  The maximum budget is $300,000USD (including 20% indirect costs) for up to 2 years.
    IDCR funding will be offered to meritorious and relevant research projects through four streams:

    • IDCR Research Grants valued at up to $250,000 over 3 years;
    • IDCR Research Grant supplements of $20,000 over one year;
    • IDCR Postdoctoral Fellowship supplements, valued at $10,000 over one year, for SSHRC Postdoctoral Fellowship holders; and
    • IDCR Doctoral Award supplements, valued at $10,000 over one year, for holders of SSHRC Doctoral Fellowships or Joseph-Armand Bombardier Canada Graduate Scholarships Program—Doctoral Scholarships.

    Various Deadlines, please check website for more details

  • UofT Town Hall on the Canadian Institutes of Health Research (CIHR)  The Office of the Vice-President, Research and Innovation, and Strategic Initiatives, invites the health and life sciences research community to a town hall to discuss the current state of CIHR and the recent evolution of its programs and priorities. The University of Toronto CIHR University Delegate, Dr. Tania Watts, will lead a facilitated session to gather input and ideas from the community that will be raised with the CIHR President, Dr. Michael Strong, when he visits the University in November. Faculty, trainees, and staff are all welcome to attend.
    DATE: Wednesday, October 23, 2019 from 2pm – 4 pm.
    LOCATION: 
    Medical Sciences Building, Room 3154, 1 King’s College Circle, University of Toronto.

Graduate Students & Postdoctoral Fellows:

  • Alzheimer’s Society Research Program 2020 Research Competition  The Alzheimer’s Society Research Program 2020 Research Competition has now been launched. ASRP has the overall objective to support Canadian studies that promise new insights into causes, prevention, diagnosis, treatment and management of Alzheimer’s disease and related dementias.  The programs offered include Doctoral Awards and Postdoctoral Awards. More details available here.
    Internal Deadline: November 1, 2019; Sponsor Deadline: November 8, 2019 by 11:59pm.
  • BrightFocus Foundation
    • Alzheimer’s Disease Research (ADR): Postdoctoral Fellowship Awards. Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant’s own independent research career. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency). All other applicants are encouraged to apply for a standard award. Amount: USD $200,000 over two years. Deadline for proposals: November 4, 2019.
  • Mitacs Globalink Research Award – Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
    Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca
  • The Mitacs Accelerate industrial postdoc provides up to 3 years of funding valued at $55,000/year for research with a company or not-for-profit, as well as access to professional skills training courses. Postdocs:
    • Build a longer-term collaboration with a company or not-for-profit
    • Apply their expertise to real-world problems
    • Connect with a potential employer

    This limited-time offering closes on December 6, 2019. With questions or for more information, contact us at accelerate@mitacs.ca.

  • Mitacs Elevate provides two years of postdoc funding valued at $60,000/year plus extensive customized professional development training ($7,500/year non-cash value). Postdocs:
    • Manage a long-term collaborative research project with a company or not-for-profit
    • Develop business-ready skills in leadership, financial literacy, management and negotiation, project management, problem solving and much more
    • Key deadlines
      • January 8, 2020 – Intent to apply and conflict of interest declaration deadline
      • February 19, 2020 – Final application deadline

    For questions or more information, please contact us at elevate@mitacs.ca.

  • 2019-2020 RBC Post-Doctoral & Graduate Fellowships  The RBC Post-Doctoral & Graduate Fellowships will support research and innovation at the University of Toronto and recognize emerging leaders who are establishing a record of research, scholarship, and impact, and exhibit the potential to make significant contributions to the body of research in the field of entrepreneurship and innovation.
    Four fellows each year will be selected from a variety of disciplines (Machine Learning and Advanced Data Analytics  & Security):
    • RBC Post-Doctoral Fellowship– 2 post-doctoral fellowships valued at $50,000 over 1 year
    • RBC Graduate Fellowship– 2 graduate student scholarships valued at $50,000 over 2 years ($25K/year for 2 years)
    In addition to research excellence, preference will be given to those who have a demonstrated and/or future interest in entrepreneurship and company creation.
    Sponsor Deadline: November 11, 2019
  • 2020 RBC Prize for Innovation and Entrepreneurship The 2020 RBC Prize for Innovation and Entrepreneurship is an annual business pitch competition offering $50,000 in prizes to recognize, reward, and accelerate the University of Toronto’s most innovative startups. Part of U of T Entrepreneurship Week True Blue Expo, the competition will take place Thursday, March 12 at MaRS. Selected individuals or teams will compete by showcasing their business idea via a five-minute pitch to a panel of judges for the following prizes:
    Early Stage Prizes*          Later Stage Prizes**
    1st Prize: $10,000             1st Prize: $25,000
    2nd Prize: $5,000              2nd Prize: $10,000
    Apply now for your chance to win prize money to take your startup to the next level!
    Deadline: Monday October 28, 2019.
  • Women’s Health Scholars Awards (funded by Ontario Ministry of Health and Long-Term Care)  The awards program in Women’s Health has been established to ensure that Ontario attracts and retains pre-eminent women’s health scholars. The community of women’s health scholars fostered by this Awards program will excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge about women’s health and its translation into improved health for women, more effective health services and products for women, and a strengthened heath care system.  The program offers funding for Master’s students, doctoral students and postdoctoral fellows.  
    Internal Deadline: December 2, 2019; Sponsor Deadline: January 31, 2020.

Undergraduate Students:

  • Mitacs Globalink Research Award – Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
    Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca